Switzerland: Lunaphore closes Series C funding

The founders of Lunaphore

Lausanne-based cancer research and tissue diagnostics company Lunaphore Technologies has closed its Series C funding for the second time at SFr25m (US$25.7m). The SFr2m Series C2 financing was provided by the Swiss Entrepreneurs Fund, which has invested a total of SFr5m in the company. The fund is linked to the Swiss Entrepreneurs Foundation, whose main…

You must be a HMI Subscriber to view this content.

Subscribe Now »